Published: 27 May 2024
Genève
100%
Permanent position
Job ads found online
Johnson & Johnson is currently seeking an Associate Director, Autologous Cell Therapy Process Development to join our API Cell and Gene Therapy Organization located in Spring House, PA or Raritan, NJ.
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com/.
We are seeking an energetic and highly motivated candidate for the role of Associate Director, who possesses proven expertise in autologous cell therapy process development. The ideal candidate will be responsible for late-stage process development of autologous cell therapies, with a strong focus on process improvement, life-cycle management, and tech transfer. This role involves integrating new equipment/technologies, developing unit operations, and investigating root causes to facilitate transformative manufacturing processes for cGMP Manufacturing. The successful candidate will oversee the monitoring of Critical Process Parameters (CPP) and Critical Quality Attributes (CQAs) using statistical analysis, ensuring the robustness and capability of manufacturing processes. They will also identify and implement process improvements to support the commercialization of cell therapy products. This position requires collaboration with a cross-functional team to support CMC development and commercial production.
Key Responsibilities